Elevance Health Inc.

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Humana shares surge 15% near $446: Is the 2028 Medicare recovery already priced in?

Humana shares have surged after 95% of its Medicare Advantage members qualified for plans rated four stars or higher in 2027. The improvement strengthens its 2028 payment outlook, but the stock's valuation depends on how much additional revenue becomes sustainable profit.

bySrinath

October 9, 2026

Why are U.S. health insurers crashing? Medicare fears hit Humana, UnitedHealth, CVS

Find out why Humana, UnitedHealth, CVS, and Commvault were among the top U.S. stock losers on January 27, 2026. Read the full sector breakdown now.

byPallavi Madhiraju

January 28, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Humana shares surge 15% near $446: Is the 2028 Medicare recovery already priced in?

Why are U.S. health insurers crashing? Medicare fears hit Humana, UnitedHealth, CVS

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?